Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports
Resumenes AASLD-2016-GEHEP
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Incremental cost and effectiveness of SOF/LDV and SOF/VEL relative to... | Download Scientific Diagram
Pooling SAE rates of SOFL/LDV regimen on HCV genotype 6. SAE, serious... | Download Scientific Diagram
Incremental cost and effectiveness of SOF/VEL relative to SOF/LDV in... | Download Scientific Diagram
Simulation plot predicting the probability of LDV-resistant mutant... | Download Scientific Diagram
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
Figure 4, Illustration of the Sensitivity of LDV/SOF Sustained Virologic Response to One (LDV/SOF 22/1) and Two (LDV/SOV 22/2) Additional Data Points - Ledipasvir/Sofosbuvir (Harvoni) - NCBI Bookshelf
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data | PLOS ONE
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports
Tratamiento de la hepatitis C en el pre- y postrasplante hepático | Gastroenterología y Hepatología
Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b - Zakalashvili - 2021 - Hepatology Research - Wiley Online Library
ION-3 Study: LDV/SOF + RBV for naïve genotype 1 - ppt download
ION-1 Design LDV/SOF LDV/SOF + RBV Randomisation* 1 : 1 : 1 : 1 Open-label ION-1 Study: LDV/SOF + RBV for genotype 1 W24W12 ≥ 18 years Chronic HCV infection. - ppt download
Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C | Hepatitis Monthly | Full Text
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C - ScienceDirect
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis - ScienceDirect
RASs found pre- and post-treatment with LDV/SOF + RBV detected as low... | Download Scientific Diagram
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study | PLOS ONE
Antiviral activity of LDV and SOF as monotherapy (A) and combination... | Download Scientific Diagram
